Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -1.88% | 152.81 | 0.0% | $2720.11m | |
| BNGO | BioNano Genomics, Inc. | -7.07% | 10.26 | 0.0% | $2116.05m | |
| GILD | Gilead Sciences, Inc. | -1.02% | 64.81 | 1.0% | $642.28m | |
| AMGN | Amgen, Inc. | -0.03% | 250.98 | 1.3% | $589.27m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.25% | 522.00 | 2.7% | $496.54m | |
| ILMN | Illumina, Inc. | -0.92% | 428.09 | 3.5% | $487.75m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.42% | 155.03 | 2.0% | $464.00m | |
| CRSP | CRISPR Therapeutics AG | -1.80% | 161.00 | 0.6% | $428.96m | |
| NVAX | Novavax, Inc. | -2.42% | 128.00 | 92.9% | $404.60m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.70% | 223.67 | 1.9% | $375.62m | |
| SRPT | Sarepta Therapeutics, Inc. | -4.65% | 86.28 | 13.8% | $324.95m | |
| SRNE | Sorrento Therapeutics, Inc. | -4.79% | 14.50 | 1.4% | $318.60m | |
| BIIB | Biogen, Inc. | -0.23% | 264.55 | 1.7% | $313.63m | |
| BNTX | BioNTech SE | 0.03% | 106.00 | 0.0% | $293.62m | |
| EXAS | EXACT Sciences Corp. | 0.00% | 136.85 | 19.6% | $253.85m |
Company Profile
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.